Brachytherapy improves outcomes in young men (≤60 years) with prostate cancer: A SEER analysis

In men ≤60 years of age with prostate cancer, radiation therapy continues to offer excellent outcomes. After adjusting for relevant variables, the use of brachytherapy was associated with reduced PCSM compared to treatment with EBRT alone.